Contraceptive Pills Market to Grow with a CAGR of 6.11% through 2028

Rising consumer consciousness regarding family planning and the increasing population is expected to drive the Global Contraceptive Pills Market growth in the forecast period, 2024-2028.

According to TechSci Research report, “Contraceptive Pills Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Contraceptive Pills Market stood at USD 30.46 billion in 2022 and is anticipated to grow with a CAGR of 6.11% in the forecast period, 2024-2028. The escalating number of unintended births is a major catalyst behind the growing demand for contraceptive drugs, consequently fueling the expansion of the global contraceptive drugs market.

An important driver that is propelling the growth of this market is the increased emphasis placed by prominent industry players and healthcare organizations on raising awareness through public programs, aimed at broadening the accessibility to a range of contraceptive drug options. Moreover, during the projected period, the growth of the global contraceptive drugs market is expected to be fueled by the approval, development, and commercialization of innovative and long-lasting techniques.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Contraceptive Pills Market.”

Several factors are driving market growth, including the increasing incidence of sexually transmitted diseases, a rising rate of unintended pregnancies, and government initiatives. The global prevalence of unwanted pregnancies is a major concern, with approximately half of all pregnancies worldwide being unintended. According to the United Nations Population Fund, around 121 million unintended pregnancies occur each year, with over 60% ending in abortion. Alarmingly, an estimated 45% of abortions are unsafe, contributing to maternal fatalities and jeopardizing the achievement of Sustainable Development Goals. Moreover, a study published in BMC Pregnancy and Childbirth 2021 revealed that approximately 85 million women worldwide are affected by unintended pregnancies, with India alone accounting for a significant portion. In particular, Uttar Pradesh, India's most populous state, has a disproportionately high unwanted fertility rate compared to the rest of the country. Consequently, the increasing number of unintended pregnancies is expected to drive the demand for contraceptive drugs and devices, thereby fueling market growth.

Furthermore, the rising prevalence of sexually transmitted diseases among the population is poised to contribute to market expansion. For example, a report by the Centers for Disease Control and Prevention highlighted a significant number of Syphilis cases, including the highly infectious primary and secondary stages. Additionally, data from the World Health Organization indicated a staggering number of new infections of sexually transmitted diseases, such as chlamydia, gonorrhea, Syphilis, and trichomoniasis. This mounting burden emphasizes the need for contraception to prevent the transmission of diseases, thus stimulating market growth.

Moreover, governments worldwide have recognized the importance of curbing unplanned pregnancies and have implemented various campaigns to educate and prevent such occurrences. The promotion and support of voluntary family planning and reproductive health initiatives by organizations like the United States Agency for International Development exemplify this commitment. Additionally, government-led programs, such as the National Chlamydia Screening Program in the United Kingdom, aim to reduce the risk of untreated chlamydia infection through timely testing, treatment, and re-testing. These government initiatives play a crucial role in promoting the use of contraceptive methods to avoid unnecessary births and abortions. While these factors contribute to market growth, challenges persist, such as the high cost of devices and treatment, as well as potential side effects associated with contraceptive drugs and devices. These factors may hinder market growth over the forecast period.

The Global Contraceptive Pills Market is segmented into pill type, category, sales channel, regional distribution, and company.

Based on sales channel, the market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. The retail pharmacy segment has emerged as the dominant player in the contraceptive market, contributing significantly to overall revenue in 2022. This can be attributed to the rising demand for contraceptive pills among the general public, driven by factors such as increasing awareness of different contraceptive options and their effectiveness. With the easy availability of birth control tablets over the counter in many countries, more and more customers are turning to retail pharmacies as their go-to source for reliable supply. Moreover, the growth of the retail pharmacy segment is also bolstered by favorable regulations that support the accessibility and affordability of contraceptive drugs. These regulations not only facilitate the smooth operation of retail pharmacies but also ensure that customers have a wide range of contraceptive options to choose from, further fueling the demand for these products.

On the other hand, the online distribution channel segment is projected to witness the fastest growth rate during the forecast period. This can be attributed to the increasing preference for over-the-counter solutions, coupled with the convenience of online shopping and the availability of attractive discounts and offers. Online platforms provide a convenient and discreet way for customers to access contraceptive products, making them a popular choice for those seeking privacy and convenience. The retail pharmacy segment holds the largest share of revenue in the contraceptive market, driven by the growing demand for contraceptive pills and favorable regulations. Simultaneously, the online distribution channel is experiencing rapid growth due to the increasing utilization of over-the-counter solutions and the availability of enticing discounts and offers. These trends indicate a dynamic and evolving landscape in the contraceptive market, with both traditional and online channels playing crucial roles in meeting the diverse needs of consumers.

Based on region, North America segment is expected to grow during the forecast period. North America is projected to dominate the market for contraceptive drugs and devices during the forecast period. This can be attributed to various factors such as the increasing incidence of unwanted pregnancies and high abortion rates, the presence of advanced healthcare infrastructure, the high adoption rate of contraceptive drugs and devices, and the growing number of government initiatives.

A significant portion of the female population in the United States and Canada falls within the reproductive age group. Hence, the rising cases of unwanted pregnancies and abortion rates are key drivers of market growth in the region. For example, according to statistics published by the Pew Research Center in June 2022, there was an increase in the number of recorded abortions to 930,160 in 2020 compared to the previous year. Consequently, the rising number of abortion cases in the country is expected to drive the demand for various contraceptive methods to prevent unwanted pregnancies, thereby propelling market growth.

The increasing prevalence of sexually transmitted diseases among the population in the region also contributes to market growth. The rising burden of these diseases is expected to drive the demand for male condoms, which provide protection against pathogens such as gonorrhea, herpes simplex virus (HSV), hepatitis B, HIV, and chlamydia. This is anticipated to fuel market growth in the region throughout the forecast period.

Major companies operating in Global Contraceptive Pills Market are:

• Bayer AG
• Amneal Pharmaceuticals LLC
• Teva Pharmaceuticals Industries Ltd.
• Abbvie Inc. (Allergan PLC)
• Pfizer Inc.
• Johnson & Johnson
• Aurobindo Pharma Limited
• Organon International (Merck & Co. Inc.)
• Sanofi SA
• Mayne Pharma Group Ltd

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The global contraceptive drugs market is driven by factors such as increasing consumer consciousness about family planning, rising population, and growing instances of unintended pregnancies. Healthcare practitioners are increasingly favoring modern contraceptive methods due to their multiple benefits, leading to better clinical outcomes and optimal safety. The market is also supported by frequent approvals of novel medications by regulatory bodies. Innovations like gelatin capsules and non-hormonal vaginal gels are further propelling market growth. Continuous R&D activities and initiatives by NGOs and health agencies to educate consumers about contraception techniques, women's health, and sexual wellness are positively impacting the market.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Contraceptive Pills Market Segmented By Pill Type (Progestin Pills & Combination Pills), By Category (Generic & Branded), By Sales Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region and Competition, Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Contraceptive Pills Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Contraceptive Pills Market.